Intranigral injected iron progressively reduces striatal dopamine metabolism. 1994

W Wesemann, and S Blaschke, and M Solbach, and C Grote, and H W Clement, and P Riederer
Department of Neurochemistry, Institute of Physiological Chemistry, Marburg, Federal Republic of Germany.

The striatal dopamine metabolism of the rat was followed 1, 3, and 6 weeks after unilateral intranigral iron (III) (50- and 1.5 micrograms) application. For both concentrations a progredient decrease of extraneuronal 3.4-dihydroxyphenylacetic acid (DOPA) levels was observed in the ipsilateral striatum.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008297 Male Males
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005290 Ferric Compounds Inorganic or organic compounds containing trivalent iron. Compounds, Ferric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D015102 3,4-Dihydroxyphenylacetic Acid A deaminated metabolite of LEVODOPA. DOPAC,Homoprotocatechuic Acid,3,4-Dihydroxyphenylacetic Acid, Monosodium Salt,3,4 Dihydroxyphenylacetic Acid
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

W Wesemann, and S Blaschke, and M Solbach, and C Grote, and H W Clement, and P Riederer
April 1989, Pharmacology, biochemistry, and behavior,
W Wesemann, and S Blaschke, and M Solbach, and C Grote, and H W Clement, and P Riederer
April 1998, Free radical biology & medicine,
W Wesemann, and S Blaschke, and M Solbach, and C Grote, and H W Clement, and P Riederer
November 1988, Journal of neurochemistry,
W Wesemann, and S Blaschke, and M Solbach, and C Grote, and H W Clement, and P Riederer
March 1988, Brain research,
W Wesemann, and S Blaschke, and M Solbach, and C Grote, and H W Clement, and P Riederer
December 1990, Acta physiologica Scandinavica,
W Wesemann, and S Blaschke, and M Solbach, and C Grote, and H W Clement, and P Riederer
January 1995, Journal of neural transmission. Supplementum,
W Wesemann, and S Blaschke, and M Solbach, and C Grote, and H W Clement, and P Riederer
January 1982, Journal of neural transmission,
W Wesemann, and S Blaschke, and M Solbach, and C Grote, and H W Clement, and P Riederer
January 1991, Neurotoxicology and teratology,
W Wesemann, and S Blaschke, and M Solbach, and C Grote, and H W Clement, and P Riederer
January 1995, Journal of neural transmission. Supplementum,
W Wesemann, and S Blaschke, and M Solbach, and C Grote, and H W Clement, and P Riederer
February 2006, Brain research,
Copied contents to your clipboard!